Mission: Miami Cancer Institute provides comprehensive care, to patients with cancer and their families, in a multi-disciplinary setting, with the most innovative, evidence-based approaches available. We focus on compassionate care, delivered in a timely manner, with ready access to highly skilled and professional teams of caregivers.
Vision: Miami Cancer Institute strives to be the preferred treatment destination, for patients with cancer and their families-locally, regionally, and internationally. Our team will work together to accelerate progress toward our ultimate goal of finding a cure.
Miami Cancer Institute brings together world-class cancer experts and an unmatched dedication to multidisciplinary patient care, cutting-edge technology and innovative cancer treatments. Enhanced by an alliance with Memorial Sloan Kettering – a leading academic cancer center, our 140,000-square-foot research facility provides patients access to clinical trials and ground-breaking treatments that could lead to positive outcomes. Miami Cancer Institute is a symbol of medical excellence in every aspect of cancer care, from diagnosis to treatment to research. It also is a symbol of hope, faith and caring, from the building’s design to the skilled physicians, nurses and staff who care for our patients.
8900 North Kendall Drive
Miami, Florida 33176
Conveniently located on the northeast corner of the Baptist Hospital campus, Miami Cancer Institute provides a comprehensive range of cancer treatments and services in its 445,000 square-foot, state-of-the-art flagship facility.
The Miami Cancer Institute has about 1,300 total employees which includes 82 physicians and 106 Advance Practice Providers.
Miami Cancer institute is an MSK Alliance Partner. The Cancer Alliance is a unique partnership between Memorial Sloan Kettering Cancer Center and oncology providers like Miami Cancer Institute. Our two organizations work together to adopt into everyday practice at Miami Cancer Institute the Cancer Alliance standards of care. Additionally we are certified by QOPI and Commission on Cancer.
INTRODUCTION TO PHARMACY SERVICES STAFF W/BRIEF BIO:
The Miami Cancer Institute has an oncology sub-specialized and decentralized pharmacy practice model, bringing pharmacy professionals to infusion suites and clinics, allowing for more readily available pharmacy services and close interaction with patients and the multidisciplinary care team. Primary pharmacy service lines include standard of care infusion, investigational drug services (IDS) infusion, inpatient/outpatient auto- and allogeneic bone marrow transplant, and oral oncolytic monitoring services. Pharmacy services are expanding rapidly to meet the demands of a growing oncology program.
The pharmacy team is composed of an Assistant Vice President of Oncology Pharmacy, Director of Pharmacy, several managers, supervisors and coordinators, as well as a large group of high-dedicated, highly-motivated, and hardworking group of pharmacy technicians, pharmacy auditors, oncology informatics pharmacists, oncology pharmacy residents, clinical pharmacists and clinical pharmacy specialists.
The Miami Cancer Institute houses its own Specialty Pharmacy which provides services throughout the health system. This pharmacy has a specialized dispensing and monitoring clinical teams to provide oncology-specific services.
Treatments & Services offered at Miami Cancer Institute include: Radiation Therapy, Interventional Oncology, Genetic Counseling & Testing, Pediatric Cancer Care, Surgery, Diagnostic Testing, Clinical Trials & Research, Preventative Screenings, Proton Therapy, Chemotherapy Outpatient Infusion Services.
WHY DID YOU JOIN NCODA?
NCODA has a patient advocacy focused mission which aligns with our goals and mission. Additionally, NCODA provides the opportunity to understand how health systems and different dispensary settings can collaborate and partner to advance the patient experience with oral specialty treatments.
HOW DID YOU BECOME A MEMBER?
Connecting with the NCODA leadership allowed us to learn more about the organization and pursue membership.
HOW DID YOU HEAR ABOUT US?
We learned about NCODA through a networking event.
HOW CAN NCODA HELP YOU?
Having access to Quality Standards as well as Oral Chemotherapy Education sheets for patients will greatly improve the care and the information that we provide.
HOW WOULD YOU LIKE TO BE MORE INVOLVED WITH NCODA?
I would like to see NCODA recognize at national meetings practice that bring novel contributions to the oncology professional community as a way to promote quality and innovation in the field.
WHAT ARE SOME CHALLENGES YOU FACE NOW OR WILL FACE IN THE FUTURE OF ONCOLOGY?
Access to oral chemotherapy agents continues to be challenging at times. Additionally there has been a steady increase in the number of oral oncolytics that are approved and although administration of treatment at home is convenient for patients, the complexities and toxicities of the agents continues. Continuous monitoring and follow-up with patients is key in obtaining optimal results with little adverse effects.